LANSDOWNE PARTNERS AUSTRIA GMBH
Follow13F filer, CIK 1536071, Vienna, Austria
LANSDOWNE PARTNERS AUSTRIA GMBH reported $6,518,000 across 1 holding for the quarter ended 2014-06-30, in a 13F-HR filed 2014-08-13.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000919574-14-004368
- Period
- 2014-06-30
- Reported value
- $6.52M
- Holdings
- 1
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 0
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| ALEXZA PHARMACEUTICALS INCadded | +70,980 | $324K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
None.
Holdings, Q2 2014
Share positions as resolved from 13F-HR 0000919574-14-004368, largest first. % of portfolio is the value over $6,518,000, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| ALEXZA PHARMACEUTICALS INCALEXZA PHARMACEUTICALS INC | 1,426,235 | $6.52M | 100% | +70,980 |
How Q2 2014 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000919574-14-004368 | base | 2014-08-13 | acceptance time not in the bulk data set |